ArticleTranslational psychiatry2026
Correlation networks of blood proteins in the neuroimmunology of schizophrenia-replication and extension.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
The Pearson sample correlation between two biomarkers across a group of individuals can sometimes be much stronger than expected by chance. In the context of psychosis risk, we previously analyzed blood plasma protein data from initial presentations as collected in the North American Prodrome Longitudinal Study 2 (NAPLS2). We found enhanced correlation between proteins SERPINE1 and TIMP1, both promoters of coagulation and inhibitors of remodeling of extracellular matrix (ECM). Participants were unaffected community controls vs. others of clinical high risk. The SERPINE1-TIMP1 correlation was consistently higher in individuals at clinical high risk for psychosis who later converted to a psychotic disorder vs. participants who were nonconverters or unaffected community controls. Here, we extend those findings using data from a larger cohort, the North American Prodrome Longitudinal Study 3 (NAPLS3). Again, the correlation between SERPINE1 and TIMP1 remained higher in psychosis high-risk converters vs. the other groups. In NAPLS3 we added an assay for PLAT (anti-coagulation plasminogen activator strongly inhibited by SERPINE1). Comparing the three NAPLS3 groups we found a decreased correlation between SERPINE1 and PLAT in converters. In summary, the increased correlation of SERPINE1 and TIMP1 in converters is consistent with restricted brain circuit remodeling and increased tendency to coagulation. Rigorous application of permutation testing yielded NAPLS2 vs. NAPLS3 consistency of SERPINE1-TIMP1 correlation patterns with empirical p-value 0.03.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.